Clinical significance of interstitial lung abnormalities and immune checkpoint inhibitor‐induced interstitial lung disease in patients with non‐small cell lung cancer

BACKGROUND: Interstitial lung abnormalities (ILAs) are known to be a risk of drug‐induced pneumonitis. However, there are few reports on the relationship between ILAs and immune checkpoint inhibitor‐related interstitial lung disease (ICI‐ILD). We retrospectively investigated the clinical significanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Murata, Daiki, Azuma, Koichi, Matama, Goushi, Zaizen, Yoshiaki, Matsuo, Norikazu, Murotani, Kenta, Tokito, Takaaki, Hoshino, Tomoaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807441/
https://www.ncbi.nlm.nih.gov/pubmed/36377039
http://dx.doi.org/10.1111/1759-7714.14718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807441/
https://www.ncbi.nlm.nih.gov/pubmed/36377039
http://dx.doi.org/10.1111/1759-7714.14718

Ejemplares similares